An AUC of 0.82 with a defined cutoff of 1.325 μg/mL indicates strong sensitivity and specificity, suggesting that adipsin may serve as a valuable adjunct biomarker in the early identification of RA, where timely diagnosis and intervention are critical. Here, CFD is linked to rheumatoid arthritis.